| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.0041 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |